Paysign FY2025 revenue $82.0M (+40.5%); guides FY2026 revenue $106.5-110.5M, net income nearly doubles

Paysign, Inc.

Full-year 2025 total revenues $82.0M (up 40.5% YoY); net income $7.55M ($0.13 diluted EPS) vs $3.82M ($0.07) in 2024.
Adjusted EBITDA $19.94M (up 107.3% YoY); pharma revenue +167.8% to $33.89M on 55 new patient affordability programs.
Added 115 net plasma centers (595 total); plasma revenue +4.0% to $45.62M.
Gamma acquisition (BECS under FDA review) closed March 2025; exited with $21.07M cash, zero debt.
FY2026 guidance: revenue $106.5-110.5M (30-35% growth), net income $13-16M ($0.21-0.26 EPS), adjusted EBITDA $30-33M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Paysign, Inc. reported fourth quarter 2025 results: revenue total revenues of $22.76 million, net income net income of $1.36 million, EPS $0.02 per diluted share.

Period: fourth quarter 2025
Revenue: total revenues of $22.76 million
Net income: net income of $1.36 million
EPS: $0.02 per diluted share
Result: reported results

Exact text from the filing

Fourth quarter 2025 total revenues of $22.76 million, up 45.8% from fourth quarter 2024

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.

Period: full-year 2025
Net income: net income of $7.55 million
Result: reported results

Exact text from the filing

Full-year 2025 total revenues of $82.0 million, up 40.5% from 2024

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.

Period: full-year 2025
Net income: net income of $7.55 million
Result: reported results

Exact text from the filing

Total revenues increased 40.5%, or $23.64 million to $82.02 million from $58.38 million in 2024.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Paysign, Inc. reported full-year 2025 results: net income net income of $7.55 million.

Period: full-year 2025
Net income: net income of $7.55 million
Result: reported results

Exact text from the filing

Full-year 2025 net income of $7.55 million, or $0.13 per diluted share, versus net income of $3.82 million, or $0.07 per diluted share for full-year 2024

View on SEC.gov

Browse all earnings releases →

Paysign, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-26-002168

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.